School of Medicine

Shin-ichiro Imai, MD, PhD, is a professor of developmental biology and of medicine at Washington University School of Medicine in St. Louis. Over the past three decades, his research has shed light on the processes of aging and longevity as he has sought to help people maintain better health into later years.

The Office of the Vice Chancellor for Research has announced the eight winners of the 2014 University Research Strategic Alliance (URSA) grants. The URSA program aims to encourage new groups of investigators working on new research or using new approaches to solve problems.

A pair of papers from researchers at the Washington University School of Medicine in St. Louis are among those chosen as the best papers published by The Journal of Biological Chemistry during 2014.

Linda J. Pike, PhD, professor of biochemistry and molecular biophysics at Washington University School of Medicine in St. Louis, received a four-year, $1.76 million grant from the National Institute of General Medical Sciences for research titled “Signal Transduction by ErbB2/ErbB3 Oligomers.”

Beginning at 6 p.m., Monday, Feb. 2, Taylor Avenue between McKinley and Clayton avenues will be reduced to two lanes of traffic each night until Feb. 11 for the installation of Ameren substation feeder conduits below Taylor.

A mosquito-borne virus that has spread to the Caribbean and Central and South America and has caused isolated infections in Florida often causes joint pain and swelling similar to that seen in patients with rheumatoid arthritis, according to new research from the School of Medicine.

Women whose bodies have high levels of chemicals found in plastics, personal-care products, common household items and the environment experience menopause two to four years earlier than women with lower levels of these chemicals, according to a new study.

At 9 a.m., Friday, Jan. 30, contractors will close one lane of northbound Kingshighway Boulevard, just north of Children’s Place and extending past Parkview Place, to begin construction of a tower crane. The lane will reopen at 3 p.m. the same day.

The Food and Drug Administration (FDA) has approved for testing in people a nanoparticle-based imaging agent jointly developed at the School of Medicine and collaborating institutions. The imaging agent may illuminate dangerous plaque in arteries, and doctors hope to use it to identify patients at high risk of stroke.

Andwele M. Jolly, manager of business operations for the Divisions of Allergy & Immunology and of Rheumatology at Washington University School of Medicine in St. Louis, has been elected to the board of directors of the Missouri Foundation for Health.